Document:

EX-10.26

 Exhibit 10.26 
  

			
	

	  	 Mondelēz Global LLC

Deerfield, IL 60015 USA

 mondelezinternational.com 

PRIVATE AND CONFIDENTIAL 
 James Kehoe 

October 25, 2013 
 OFFER LETTER 

Dear James, 
 I am very pleased to provide you with this letter
confirming the verbal offer that has been extended to you for the position of Senior Vice President Operational Excellence for Mondelēz International. This position will report to Irene Rosenfeld Chairman and Chief Executive Officer. 

You are being offered the position as a United States local employee. As such, you will be hired as a U.S. employee, compensated within the U.S. compensation
structure and be subject to U.S. employment laws. This offer is subject to your acceptance of the terms and conditions outlined in this letter and the granting of a work permit where applicable.  

The effective date of the appointment will be as soon as possible following the successful attainment of a proper visa for you to work for us in the United
States. 
 Annualized Compensation (Target Opportunity) 
  

									
	 Annual Base Salary
	  	 	USD	  	  	 	475,000	  
	 Annual Incentive Plan (Target *- 55%)
	  	 	USD	  	  	 	261,250	  
	 Long Term Incentives**
	  	 	USD	  	  	 	710,000	  
	 -Performance Shares (Target *- 60%)
	  	 	USD	  	  	 	285,000	  
	 -Target Stock Award Value
	  	 	USD	  	  	 	425,000	  
	 Total Target Compensation
	  	 	USD	  	  	 	1,446,250	  

  

	*	Target as a percent of base salary. 

  
 

 

			
	

	  	 Mondelēz Global LLC

Deerfield, IL 60015 USA
  

mondelezinternational.com

  

	**	The value of the long-term incentive awards reflects the “economic value” of equity awards. For performance and restricted shares, the value reflects grant value. For stock option value, the value approximates
the Company’s Black-Scholes value. 

 With this assignment, your base salary will be quoted in USD and will be reviewed in line with our
U.S. compensation practices. Your next anticipated salary review will be April 1, 2014. 
 Annual Incentive Plan 

You will be eligible to participate in the Mondelēz International Management Incentive Plan (MIP), which is the Company’s annual incentive program.
Your target award opportunity under the MIP is equal to 55% of your base salary. The actual amount you will receive may be lower or higher depending on your individual performance and the performance of the Company overall. The maximum award under
this program is 250% of your target opportunity. Your MIP eligibility will begin on your date of employment. 
 Long-Term Incentive Plan 

Performance Shares 
 Your eligibility for the Mondelēz
International performance share program (referred to as the Long-Term Incentive Plan or LTIP will commence with the 2014 – 2016 performance cycle. Your target opportunity under the LTIP is equal to 60% of your base salary at the beginning of
the performance cycle and your target award will be based on the full performance cycle. The actual award you will receive may be lower or higher depending upon the performance of Mondelēz International, Inc. during the performance cycle. The
number of performance shares under the 2014 – 2016 performance cycle is equal to your target value divided by the fair market value of Mondelēz International stock on the first business day of the performance cycle. 

The 2014-2016 performance shares will vest in early 2017. You will receive accumulated dividend payments at the end of the vesting period based on the actual
number of shares vested. It is anticipated that a new three year performance cycle will begin each year in January. Beginning in 2017, if you remain employed and performance is above threshold, performance shares will vest each year at the
conclusion of each performance cycle. 
 Equity Program – Restricted Stock and Stock Options 

You will also be eligible to participate in the Company’s restricted stock and stock option award program. Stock awards are typically made on an annual
basis, with the next award anticipated to be granted in the first quarter of 2014. Awards have historically been delivered as follows: 50% of equity value is delivered in restricted stock and 50% in stock options. Actual award size is based on
individual potential and performance. You will receive dividends on the restricted shares during the vesting period consistent in amount and timing with that of Common Stock shareholders. 

  
 

 

			
	

	  	 Mondelēz Global LLC

Deerfield, IL 60015 USA
  

mondelezinternational.com

  

 The number of stock options granted is typically communicated as a ratio relative to the number of restricted
shares granted based on the “economic value” of the stock options. In 2013, Mondelēz International granted 5 stock options for every restricted share awarded. This ratio may change from year to year. 

Sign On Incentives 
 As part of your employment
offer, as an incentive to join Mondelēz International, upon hire, you will receive sign-on incentives in the form of cash and stock as follows: 
  

			
	Cash Sign-On Incentive:	  	$100,000 with a two-year repayment agreement, payable at date of hire.
	Equity Sign-On Incentive:	  	$2,500,000 delivered partially as restricted stock (75%) and partially as stock options (25%) to vest as follows:
		  	 •       50% on your 1st
anniversary;

		  	 •       25% on your 2nd anniversary
and

		  	 •       25% on your 3rd
anniversary

 The actual number of shares that you will receive will be determined based upon the fair market value of Mondelēz
International, Inc. Common Stock on your date of hire. You will be paid cash dividends on the restricted shares during the vesting period consistent in amount and timing with that of Common Stock shareholders. 

In the event that you are involuntarily terminated for reasons other than cause prior to the full vesting of your sign-on equity, you will fully vest in the
awards on the effective date of your termination. 
 For purposes of this offer letter, “cause” means: 1) continued failure to substantially
perform the job’s duties (other than resulting from incapacity due to disability); 2) gross negligence, dishonesty, or violation of any reasonable rule or regulation of the Company where the violation results in significant damage to the
Company; or 3) engaging in other conduct which materially adversely reflects on the Company. 
 The other terms and conditions set forth in Mondelēz
International’s standard Stock Award Agreement will apply. 

  
 

 

			
	

	  	 Mondelēz Global LLC

Deerfield, IL 60015 USA
  

mondelezinternational.com

  

 Perquisites 

You will be eligible for a company car allowance equal to $15,000 per year under the executive perquisite policy. You will also be eligible for an annual
financial counseling allowance of $7,500. You may use any firm of your choosing and submit payments directly to the Company. 
 Deferred Compensation
Program 
 You will be eligible to participate in the Executive Deferred Compensation Program. This program allows you to voluntarily defer a portion
of your salary and/or your annual incentive to a future date. Investment opportunities under this program are designed to mirror the Company’s 401(k) plan. Additional information for this program can be made available upon request. 

Stock Ownership Guidelines 
 You will be required
to attain and hold Company stock equal in value to $800,000. You will have five years from your date of employment to achieve this level of ownership. Stock held for ownership determination includes common stock held directly or indirectly, unvested
restricted stock or share equivalents held in the Company’s 401(k) plan. It does not include stock options or unvested performance shares. 

Other Benefits 
 If we mutually agree to terminate
your employment in the future, your severance pay will be determined at that time in line with other similarly situated senior executives. 
 Your offer
includes Mondelēz International’s comprehensive benefits package available to full-time salaried employees. Details and terms will be provided separately. You will be eligible for 30 days of paid time off. 

Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) 

If you are subject to US tax law and if you are a “specified employee” (within the meaning of Code section 409A) as of your separation from service
(within the meaning of Code section 409A): (a) payment of any amounts under this letter (or under any severance arrangement pursuant to this letter) which the Company determines constitute the payment of nonqualified deferred compensation
(within the meaning of Code section 409A) and which would otherwise be paid upon your separation from service shall not be paid before the date that is six months after the date of your separation from service and any amounts that cannot be paid by
reason of this limitation shall be accumulated and paid on the 

  
 

 

			
	

	  	 Mondelēz Global LLC

Deerfield, IL 60015 USA
  

mondelezinternational.com

  

 
first day of the seventh month following the date of your separation from service (within the meaning of Code section 409A); and (b) any welfare or other benefits (including under a
severance arrangement) which the Company determines constitute the payment of nonqualified deferred compensation (within the meaning of Code section 409A) and which would otherwise be provided upon your separation from service shall be provided at
your sole cost during the first six-month period after your separation from service and, on the first day of the seventh month following your separation from service, the Company shall reimburse you for the portion of such costs that would have been
payable by the Company for that period if you were not a specified employee. 
 Payment of any reimbursement amounts and the provision of benefits by the
Company pursuant to this letter (including any reimbursements or benefits to be provided pursuant to a severance arrangement) which the Company determines constitute nonqualified deferred compensation (within the meaning of Code section 409A) shall
be subject to the following: 
  

	(a)	the amount of the expenses eligible for reimbursement or the in-kind benefits provided during any calendar year shall not affect the amount of the expenses eligible for reimbursement or the in-kind benefits to be
provided in any other calendar year; 

  

	(b)	the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the calendar year in which the expense was incurred; and 

 

	(c)	your right to reimbursement or in-kind benefits is not subject to liquidation or exchange for any other benefit. 

Other Terms and Conditions 
 If legally permitted,
you will participate in the U.S. Social Security scheme. You will be a U.S. employee of Mondelēz International and your employment status will be governed by and shall be construed in accordance with the laws of the United States. As such, your
status will be that of an “at will” employee. This means that either you or Mondelēz International is free to terminate the employment relationship at that time, for any reason. 

The Company will support through our immigration advisor the application for an L1 visa for you and, if necessary or desired, a Green card application, to
allow you to continue your employment with Mondelēz International. 
 This offer is contingent upon successful completion of our pre-employment checks,
which may include a background screen, reference check and post-offer drug test pursuant to testing procedures determined by Mondelēz International. 

Should you have any questions concerning this information, please call me. 

  
 

 

			
	

	  	 Mondelēz Global LLC

Deerfield, IL 60015 USA
  

mondelezinternational.com

  

					
	 /s/ Karen May
	 		 	 October 29, 2013

	 Karen May
	 		 	Date
	 Executive Vice President Human Resources
	 		 	

 I agree to the terms and conditions stated therein and as outlined in the above Offer Letter. 

 

					
	 /s/ James Kehoe
	 		 	 October 25, 2013

	 James Kehoe
	 		 	DateEX-10.6

 Exhibit 10.6 
 Exclusive Business Cooperation Agreement 
 This Exclusive Business Cooperation Agreement
(hereinafter the “Agreement”) is made by and between the following parties on April 27, 2007 in Beijing, the People’s Republic of China (the “PRC”). 

 

			
	Party A:	  	 ShanghaiMed iKang, Inc.

	Address:	  	Room 610, Building No. 1, KunTai International Mansion, B12 Chaoyang Men Wai Street, Beijing
		
	Party B:	  	Shanghai Guobin Medical Holding Co., Ltd.
	Address:	  	15/F, Qianjiang Building, 971 Dongfang Road, Pudong New District, Shanghai

 Party A and Party B are hereinafter individually referred to as a “Party” and collectively referred to
as the “Parties”. 
 WHEREAS, 
  

	1.	Party A is a wholly foreign-owned enterprise registered in the PRC, with necessary resources to provide technical consulting services related to physical examination
and health services; 

  

	2.	Party B is a limited liability company registered in PRC, which is legally approved by the PRC authorities to engage in the investment in the medical treatment,
medicine and equipment industries, the lease of medical equipment (except for medical apparatus and instruments), as well as related consulting services; and 

 

	3.	Party A agrees to provide Party B with comprehensive business support (technical, consulting, etc.) services such as investment consulting in relation to medical
treatment, medicine and equipment during the term of this Agreement, by utilizing its advantages in human resources, technology and information. Party B agrees to accept the exclusive consulting and services provided by Party A or its designated
persons in accordance with terms and conditions set forth herein. 

 NOW, THEREFORE, through negotiation, the Parties have
reached the agreement as follows: 
  

	1.	Services Provided by Party A 

  

	 	1.1	Pursuant to the terms and conditions of this Agreement, Party B hereby appoints Party A as its exclusive service provider during the term of this Agreement to provide
comprehensive business support, technical services and consulting services, including all services as determined by Party A from time to time which are within Party B’s business scope, including, but not limited to, the investment consulting
services in relation to the medical treatment, medicine and equipment to Party B. 

  
 1 

	 	1.2	Party B agrees to accept all the consulting and services provided by Party A. Party B further agrees that, during the effective term of this Agreement, unless obtaining
the prior written consent of Party A, Party B shall not accept any services and/or supports provided by any third party, nor shall establish any cooperation with any third party, with respect to the matters contemplated herein. The Parties agree
that, Party A may designate any other party to provide Party B with the services and/or support as agreed hereunder. 

  

	 	1.3	The Provision of Services 

  

	 	1.3.1	In order to better perform this Agreement, at any time as required based on the status of operations during the effective term of this Agreement, the Parties agree to
enter into, directly or through its connected party, licensing agreements, pursuant to which Party A grants licenses of its intellectual properties to Party B, including, but not limited to, software, trademark, patents, technical secrets and
confidential information. 

  

	 	1.3.2	In order to better perform this Agreement, at any time as required based on the status of operations during the effective term of this Agreement, the Parties agree to
enter into, directly or through its connected party, equipment or asset lease agreements, pursuant to which Party A provides Party B with relevant equipment and assets for Party B’s use. 

 

	 	1.4	The Parties agree that all economic losses arising from the performance of this Agreement shall be borne by Party A. 

 

	2.	Service Fees and Payment 

The calculation and payment of the services fees as agreed by the Parties shall be determined in accordance with Appendix I hereto.

  

	3.	Intellectual Property and Confidentiality 

  

	 	3.1	Party A shall have exclusive and proprietary rights and interests to all the rights, ownership, interests and intellectual property rights arising from or created by
either Party as a result of its performance of this Agreement, including but not limited to copyright, patent, patent application rights, trademark rights, software, technical secrets, trade secrets and other intellectual properties.

  
 2 

	 	3.2	The Parties acknowledge that any oral or written information exchanged between them with respect to this Agreement is confidential. Each Party shall maintain the
confidentiality of all such information, and, without the written consent of other Party, shall not disclose any relevant information to any third party, except in the following circumstances: (a) such information is or will be in the public
domain (provided that it is not the result of an unauthorized public disclosure by the receiving party); (b) information disclosed under applicable laws or regulations or stock exchange rules or regulations; or (c) information required to
be disclosed by any Party to its legal counsel or financial advisor regarding the transaction contemplated hereunder, and such legal counsel or financial advisor are also bound by confidentiality duties similar to the duties under this section.
Disclosure of any confidential information by the staff members or agency hired by any Party shall be deemed disclosure of such confidential information by such Party, and such Party shall be liable for breach of this Agreement. This Section shall
survive the termination of this Agreement for any reason. 

  

	 	3.3	The Parties agree that this section shall survive the amendment, rescission or termination of this Agreement. 

 

	4.	Representations and Warranties 

  

	 	4.1	Party A hereby represents and warrants as follows: 

  

	 	4.1.1	Party A is a wholly foreign-owned enterprise duly registered and validly existing under the laws of the PRC, with necessary resources to provide technical consulting
services relating to physical examination and healthcare services. 

  

	 	4.1.2	Party A’s execution and performance of this Agreement is within its corporate power and business scope. Party A has taken all necessary corporate actions and
obtained all appropriate authorizations, consents and approvals from third parties and government agencies to execute and perform this Agreements; and the execution and performance of this Agreement will not violate any law or restrictions binding
or impacting on it. 

  

	 	4.1.3	This Agreement constitutes lawful, valid and binding obligations on Party A and is enforceable against Party A under the terms and conditions hereof.

  

	 	4.2	Party B hereby represents and warrants as follows: 

  

	 	4.2.1	Party B is a company duly registered and validly existing under laws of the PRC, which is legally approved by the PRC authorities to engage in the investment in medical
treatment, medicine and equipment industries, lease of medical equipment (except for medical apparatus and instruments), and the related consulting services. 

  
 3 

	 	4.2.2	Party B’s execution and performance of this Agreement is within its corporate power and business scope. Party B has taken all necessary corporate actions and
obtained all appropriate authorizations, consents and approvals from third parties or government agencies to execute and perform this Agreement, and the execution and performance of this Agreement will not violate any law or restrictions binding or
impacting on it. 

  

	 	4.2.3	This Agreement constitutes lawful, valid and binding obligations on Party B and is enforceable against Party B under the terms and conditions hereof.

  

	5.	Effectiveness and Effective Term 

  

	 	5.1	This Agreement is executed and takes effect as of the date first written above. Unless early terminated in accordance with the provisions of this Agreement or relevant
agreements separately executed between the Parties, the term of this Agreement shall be 10 years. After the execution of this Agreement, the Parties shall review this Agreement every three months to determine whether to amend or supplement the
provisions of this Agreement based on the actual circumstances by then. 

  

	 	5.2	The term of this Agreement may be extended on the same terms if confirmed in writing by Party A prior to the expiration of this Agreement. The extended term shall be
determined by Party A, and Party B shall accept such extension unconditionally. 

  

	6.	Termination 

  

	 	6.1	Unless extended in accordance with the relevant provisions of this Agreement, this Agreement shall be terminated on the expiration date. 

 

	 	6.2	During the effective term of this Agreement, unless as a result of Party A’s gross negligence or fraudulent act toward Party B, Party B may not terminate this
Agreement. Nevertheless, Party A may terminate this Agreement at any time on 30-day prior written notice to Party B. 

 

	 	6.3	The rights and obligations of the Parties under Articles 3, 7 and 8 hereof shall survive the termination of this Agreement. 

 

	7.	Governing Laws and Dispute Resolution 

  

	 	7.1	The execution, effectiveness, interpretation, performance, amendment and termination of this Agreement and the resolution of disputes hereunder shall be governed by the
laws of the PRC. 

  

	 	7.2	In the event of any dispute arises with respect to the interpretation and the performance of this Agreement, the Parties shall negotiate in good faith to resolve such
dispute. In the event the Parties fail to reach an agreement on the resolution of such a dispute within 30 days after any Party’s request for resolution of the dispute through negotiations, any Party may submit the relevant dispute to the China
International Economic and Trade Arbitration Commission for arbitration, in accordance with its then-effective arbitration rules. The arbitration shall be conducted in Beijing, and the language used during arbitration shall be Chinese. The
arbitration award shall be final and binding on both Parties. 

  
 4 

	 	7.3	Upon the occurrence of any dispute arising from the interpretation and performance of this Agreement or during the pending arbitration on any dispute, except for the
matters under dispute, the Parties to this Agreement shall continue to exercise their respective rights and perform their respective obligations under this Agreement. 

 

	8.	Indemnification 

 Party B
shall indemnify and hold harmless Party A from any loss, damage, liabilities or expenses caused by any lawsuit, claims or other demands against Party A arising from or caused by the consulting and services provided by Party A at the request of Party
B, except where such loss, damage, liabilities or expenses arise from the gross negligence or willful misconduct of Party A. 
  

	9.	Notice 

  

	 	9.1	All notices and other communications required or permitted to be given pursuant to this Agreement shall be delivered personally or sent by registered mail, postage
prepaid commercial courier service or facsimile transmission to the address of such Party set forth below. Each such notice shall also be resent by email. The dates on which such notices shall be deemed to have been effectively served shall be
determined as follows: 

  

	 	9.1.1	If given by personal delivery, by courier service or by registered mail, postage prepaid, shall be deemed effectively served on the date of delivery or refusal at the
address specified for receiving notices. 

  

	 	9.1.2	If sent by facsimile transmission, shall be deemed effectively served on the date of the successful transmission (as evidenced by an automatically generated
confirmation of transmission). 

  

	 	9.2	For the purpose of notices, the addresses of the Parties are as follows: 

  

					
	Party A:	 	 ShanghaiMed iKang, Inc.

	Address:	 	Room 610, Building No. 1, KunTai International Mansion, B12 Chaoyang Men Wai Street, Beijing
	Attention:	 	Ligang Zhang
	 Tel:
	 	 010 5879 0055

	Fax:	 	010 5879 7032

  
 5 

					
	Party B:	 	Shanghai Guobin Medical Holding Co., Ltd.
	Address:	 	15/F, Qianjiang Building, 971 Dongfang Road, Pudong New District, Shanghai
	Attention:	 	Xin Ge
	Tel:	 	021 5058 9299
	Fax:	 	021 5058 7038

  

	 	9.3	Any party may at any time change its address for receiving notices by a notice delivered to the other party in accordance with the terms hereof.

  

	10.	Assignment 

  

	 	10.1	Party B may not assign its rights and obligations under this Agreement to any third party without Party A’s prior written consent. 

 

	 	10.2	Party B hereby agrees that Party A may assign its obligations and rights under this Agreement at any time at its discretion to any third party upon written notice to
Party B a without requiring Party B’s consent. 

  

	11.	Severability 

 In the
event that one or several of the provisions of this Agreement are held to be invalid, illegal or unenforceable in any aspect under any laws or regulations, the validity, legitimacy or enforceability of the remaining provisions of this Agreement
shall not be affected or prejudiced in any aspect. The Parties shall strive in good faith to replace such invalid, illegal or unenforceable provisions with effective provisions that accomplish to the greatest extent possible the intentions of the
Parties as permitted by law, with the economic effect thereof being as close as possible to that of those invalid, illegal or unenforceable provisions. 
  

	12.	Amendments and Supplements 

Any amendment and supplement to this Agreement shall be in writing. Any amendment agreement and supplementary agreement that has been
signed by the parties in relation to this Agreement shall be an integral part of this Agreement and shall have the same legal effect as this Agreement. 
  

	13.	Language and Counterparts 

This Agreement is written in Chinese in two counterparts, with each Party holding one, and with the same legal effect. 

[The remainder of this page is intentionally left blank] 

  
 6 

 [Signature Page for Exclusive Business Cooperation Agreement] 

IN WITNESS WHEREOF, the Parties hereto have caused this Exclusive Business Operation Contract to be duly executed on their behalf
by duly authorized representatives as of the date first written above and with immediate effect upon the execution. 
  

			
	Party A:	 	 ShanghaiMed iKang, Inc.

		
	Signature:	 	 /s/ Zhang Ligang

	Name:	 	Zhang Ligang
	Position:	 	Legal Representative
		
	Party B:	 	Shanghai Guobin Medical Holding Co., Ltd.
		
	Signature:	 	 /s/ He Boquan

	Name:	 	He Boquan
	Position:	 	Legal Representative

  
 7 

 Appendix I 
 Calculation and Payment of Service Fees 
 The service fees hereunder shall be calculated
based on 0% to 100% of monthly net profit of Party B, with the actual percentage thereof being determined by Party A. 
 Party A will calculate
and sum up the service fees on a quarterly basis and correspondingly issue a notice to Party B. Party B will pay such service fees to the bank accounts as designated by Party A within 10 working days from the receipt of such notice. 

In the event that Party A deems and construes the service fee determination mechanism agreed herein no longer applicable as a result of certain reasons
and the adjustment to such mechanism necessary, Party B shall actively consult in good faith with Party A within 7 working days from its receipt of the written request of Party A with respect to the service fee adjustment, so as to determine a new
fee standard or calculation mechanism. If Party B fails to respond within 7 working days from the receipt of such adjustment notice, it shall be deemed to have consented to such adjustment of service fees. 

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]